Clinical correlates of vascular parkinsonism

Archives of Neurology

Volumn 56, Issue 1, 1999, Pages 98-102

  Winikates, John ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; LEVODOPA;

AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; GAIT DISORDER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; TREATMENT FAILURE;

AGED; ANTIPARKINSON AGENTS; CEREBROVASCULAR DISORDERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 0032961367     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.1.98     Document Type: Article

References (57)

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy ot clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
2. Critchley M. Arteriosclerotic parkinsonism. Brain 1929;52:23-83.
3. Critchley M. Arteriosclerotic pseudo-parkinsonism. In: Rose FC, Capildo R. eds. Research Progress in Parkinson's Disease. London. England: Pitman; 1981:40-42.
4. Tolosa ES, Satitamaria J, Parkinsonism and basal ganglia infarcts. Neurology. 1984;34:1516-1518.
5. Friedman A, Kang UJ, Tatemichi TK, Burke RE. A case of parkinsonism following striatal lacunar infarction. J Neurol Neurosurg Psychiatry. 1986;49:1087-1088.
6. Mayo J, Aria M, Leno C, Berciano J. Vascular parkinsonism and periarteritis nodosa. Neurology. 1986;36:874-875.
7. Quinn N, Parkes D, Janota I, Marsden CD. Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period. Mov Disord. 1986;1:65-68.
8. Murrow RW, Schweiger GD, Kepes JJ, Koller WC. Parkinsonism due to a basal ganglia lacunar state: clinicopathological correlation. Neurology. 1990;40:897-900.
9. Pulhcino P, Lichter D, Benedict R. Micrographia with cognitive dysfunction: "minimal" sequelae of a pufaminal infarct. Mov Disord. 1994;9:371-373.
10. Parkes JD, Marsden CD, Rees JE, et al. Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Q J Med. 1974;43:49-61.
11. FitzGerald PM, Jankovic J. Lower bcdy parkinsonism: evidence for a vascular etiology. Mov Disord. 1989;4:249-260.
12. Chang CM, Yu YL, Ng HK, et al. Vascular pseudoparkinsonism. Acta Neurol Scand. 1992;86:588-592.
13. Agnoli A, Baldassarre M, Stucchi R, Ruggieri S. Can cerebrovascular disease be responsible for extrapyramidal disorders and the question of arteriosclerotic parkinsonism. In: Meyer JS, Lechner H, Reivich M, Ott ED, eds. Cerebrovascular Disease 6: Proceedings of the World Federation of Neurology 13th International Salzburg Conference, September 25-27. 1986. Belle Mead, NJ: Excerpta Medica-Princeton; 1987:113-117.
14. Reider-Groswasser I. Bornstein NM, Korczyn AD. Parkinsonism in patients with lacunar infarcts of the basal ganglia. Eur Neurol. 1995;35:46-49.
15. Ikeda K, Kotabe T, Kanbashi S, Kinoshita M. Parkinsonism in lacunar infarcts of the basal ganglia. Eur Neurol. 1996;36:248-249.
16. de la Fuente Fernandez R, Lopez JM, Rey del Corral P. de la Iglesia Martinez F. Peduncular hallucinosis and right hemiparkinsonism caused by left mesencephalic infarction. J Neurol Neurosurg Psychiatry. 1994;57:870.
17. Straussberg R, Shahar E, Gat R, Brand N. Delayed parkinsonism associated with hypotension in a child undergoing open-heart surgery. Dev Med Child Neurol. 1993;35:1011-1014.
18. Hageman ATM, Horstink MWIM. Parkinsonism due to a subdural hematoma. Mov Disord. 1994;9:107-108.
19. Fahn S. Secondary parkinsonism. In: Goldensohn ES, Appel SH, eds. Scientific Approached to Clinical Neurology. Philadelphia, Pa: Lea & Febiger; 1977:1159-1189.
20. Eadie MJ, Sutherland JM. Arteriosclerosis in parkinsonism. J Neurol Neurosurg Psychiatry. 1964;27:237-240.
21. Martilla RJ, Rinne UK. Arteriosclerosis, heredity, and some previous infections in the etiology of parkinson's disease: a case-control study. Clin Neurol Neurosurg. 1976;79:46-56.
22. de Reuck J, Sieben G, de Coster W. van der Eecken H. Parkinsonism in patients with cerebral infarcts. Clin Neurol Neurosurg. 1980;82:177-185.
23. Fahn S, Eton RL, and members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: MacMillan Healthcare Information; 1987:152-163.
24. Winikates JP, Jankovic J. Vascular progressive supranudear palsy. J Neural Transm Suppl. 994;43:189-201.
25. Dyken ML, Wolf PA, Barnett HJM. et al. Risk factors in stroke: a statement for physicians by the subcommittee on risk factors and stroke of the stroke council. Stroke. 1984;15:1105-1111.
26. Rosen WG, Terry RD, Fuld PA, et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol. 1980;7:486-488.
27. Molsa PK, Paljarvi L, Rinne JO, et al. Validity of clinical diagnosis in dementia: a prospective clinicopathological correlation. Neurology. 1990;40:897-900.
28. Wade JPH. Mirsen TR, Hachinski VC, et al. The clinical diagnosis of Alzheimer's disease. Arch Neurol. 1987;44:24-29.
29. Roman GC, Tatemichi TK, Erkinjunti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
30. Chui HC, Victoroft JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992;42: 473-480.
31. Pullicino P, Benedict RHB, Capruso DX, Vella N, Withiam-Leitch S, Kwen PL, Neuroimaging criteria for vascular dementia. Arch Neural. 1996;53:723-728.
32. Zijlmans JCM, Poels PJE, Duysens J, et al. Quantitative gait analysis in patients with vascular parkinsonism. Mov Disord. 1996;11:501-508.
33. Davis PC, Mirra SS, Alazraki N. The brain in older persons with and without dementia: findings on MR, PET, and SPECT images. AJR Am J Roentgenol. 1994; 162:1267-1278.
34. Drayer BP. Imaging of the aging brain, I: normal findings. Radiology. 1988;166: 785-796.
35. Awad IA, Spetzler RF, Hodak JA, et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly, I: correlations with age and cerebrovascular risk factors. Stroke. 1986;17:1084-1089.
36. Awad IA, Spetzler RF, Hodak JA, et al. Incidental lesions noted on magnetic resonance imaging of the brain: prevalence and clinical significance in various age groups. Neurosurgery. 1987;20:222-227.
37. Gerard G. Weisberg LA. MRI periventricular lesions in adults. Neurology. 1986; 36A:998-1001.
38. Sarpel G, Chaudry F, Hindo W. Magnetic resonance imaging of periventricular fiyperintensily in a Veterans Administration hospital population. Arch Neurol. 1987; 44:725-728.
39. Schmidt R, Fazekas F, Kleinert G, et al. Magnelic resonance imaging signal hyperintensities in the deep and subcortical white matter: a comparative study between stroke patients and normal volunteers. Arch Neurol. 1992;49:825-827.
40. Sullivan P, Pary R, Telang F, et al. Risk factors for white matter changes detected by magnetic resonance imaging in the elderly. Stroke. 1990;21: 1424-1428.
41. Zimmerman RD, Fleming CA, Lee BCP, et al. Periventricular hyperintensity as seen by magnetic resonance: prevalence and significance. AJNR Am J Neuroradiol. 1986;7:13-20.
42. Fazekas R, Kleiner R, Oflenbacher H, et al. Pathological correlates of incidental MRI white matter signal hyperintensities Neurology. 1993;43:1683-1689.
43. Durif F. Pollak P, Hommel M, et al. Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson's disease. Eur Neurol 1992;32:32-36.
44. Stern MB, Bratfman BH, Skolnick BE, et al. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology. 1989;39: 1524-1525.
45. Piccini P, Pavese N, Canapicchi R, et al. White matter hyperintensities in Parkinson's disease. Arch Neurol. 1995;52:191-194.
46. Bonuccelli U, Antonio PD, Del Dotto P, et al. The elusive vascular parkinsonsim. Neurology. 1995;45(suppl4):A339.
47. Zijlmans JCM, Thijssen HOM, Vogels OJM, et al. MRI in patients suspected of vascular parkinsonism. Neurology. 1995;45:2183-2188.
48. Hupperts RMM, Lodder J, Heuts-van Raak EPM, Kessels F. Infarcts in the anterior choroidal artery territory: anatomical distribution, clinical syndromes, presumed pathogenesis and early outcome, Brain. 1994;117:825-834.
49. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain. 1994;117:859-876.
50. Baloh RW, Yue Q, Socotch TM, Jacobson KM, White matter lesions and disequilibrium in older people. I: case-control comparison. Arch Neurol. 1995;52: 970-974.
51. Baloh RW, Vinters HV. White matter lesions and disequilibrium in older people, II: clinicopathological correlation. Arch Neurol. 1995;52:975-981.
52. Thompson PD, Marsden CD. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease. Mov Disord. 1987;2:1-8.
53. Marks MH, Sage JI, Walters AS. et al. Binswanger's disease presenting as levodoparesponsive parkinsonism: clinicopathological study of three cases. Mov Disord. 1995;10:450-454.
54. Ghika J, Bogousslavsky J, Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy. Arch Neurol. 1997;54: 1104-1108.
55. van Zagten M, Lodder J, Kessels F, Gait disorder and parkinsonian signs in patients witn stroke related to small deep infarcts and white matter lesions. Mov Disord. 1998;13:89-95.
56. Jellinger KA. Parkinsonism due to Binswanger's subcortical arteriosclerotic encephalopathy. Mov Disord. 1996;11:461-462.
57. Jellinger KA. Structural basis of mental impairment in Parkinson's disease. Neuropsychiatrie. 1995;9:9-14.